Tecan Group (TCHBF) Stock Price, News & Analysis

Company Overview

Tecan Group is a Switzerland-based provider of laboratory instruments and life science solutions, specializing in automated workflow platforms for research, diagnostics and pharmaceutical applications. The company’s technologies enable precise liquid handling, sample preparation, detection and data management, helping to streamline complex laboratory processes and increase throughput in areas such as genomics, proteomics and drug discovery.

Key products include automated liquid handling workstations, microplate readers and dispensers, robotic solutions for sample management, as well as consumables and software for system control and data analysis. These integrated systems support a wide range of applications—ranging from assay development and high-throughput screening to clinical diagnostics and biobanking—by offering modularity and scalability to meet diverse laboratory requirements.

Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan Group serves customers in more than 80 countries through its global network of subsidiaries, manufacturing sites and distribution partners. The company maintains production facilities in Switzerland, Germany, the United States and China, and provides application support and service offerings to academic institutions, pharmaceutical companies, biotechnology firms and clinical laboratories worldwide.

Under the leadership of Chief Executive Officer Dr. Achim von Leoprechting, Tecan Group continues to invest in research and development, focusing on advances in automation and digital connectivity to address evolving needs in life sciences and diagnostics. The company’s commitment to innovation and quality has established it as a trusted partner for laboratories seeking to improve efficiency and reproducibility in critical workflows.

Key Stats

• Today's Range: $203.00 to $203.00
• 50-Day Range: $202.65 to $211.90
• 52-Week Range: $182.45 to $327.51
• Volume: 35 shs
• Average Volume: 921 shs
• Market Capitalization: N/A
• P/E Ratio: 47.54
• Dividend Yield: 0.74%
• Price Target: N/A
• Consensus Rating: N/A

Tecan Group Stock Analysis - MarketRank™

Tecan Group scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Tecan Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Tecan Group is 47.54, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.49.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tecan Group is 47.54, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.18.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Tecan Group has a short interest ratio ("days to cover") of 1352, which indicates bearish sentiment.

Change versus previous month

Short interest in Tecan Group has recently decreased by 7.46%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Tecan Group is a leading dividend payer. It pays a dividend yield of 4.42%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Tecan Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Tecan Group is 35.13%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Tecan Group has a short interest ratio ("days to cover") of 1352, which indicates bearish sentiment.

Change versus previous month

Short interest in Tecan Group has recently decreased by 7.46%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Tecan Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tecan Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

46.80% of the stock of Tecan Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

TCHBF Stock Analysis - Frequently Asked Questions

How have TCHBF shares performed this year?

Tecan Group's stock was trading at $208.03 at the beginning of 2025. Since then, TCHBF stock has decreased by 2.4% and is now trading at $203.00.

How do I buy shares of Tecan Group?

Shares of TCHBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:TCHBF
• CIK: N/A
• Web: www.tecan.com
• Phone: (144) 922-8888
• Fax: N/A
• Employees: 3,315
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 47.46
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A